Loading clinical trials...
Loading clinical trials...
Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monocloncal Antibody
Conditions
Interventions
benralizumab
placebo
Locations
1
United States
Bernstein Clinical Research Center
Cincinnati, Ohio, United States
Start Date
September 12, 2017
Primary Completion Date
November 6, 2018
Completion Date
November 6, 2018
Last Updated
July 10, 2019
NCT03858634
NCT05774639
NCT02031679
NCT00866788
NCT02166151
Lead Sponsor
Jonathan A. Bernstein, MD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions